C-di-GMP protects against intranasal Acinetobacter baumannii infection in mice by chemokine induction and enhanced neutrophil recruitment

International Immunopharmacology

Volumn 11, Issue 9, 2011, Pages 1378-1383

  Zhao, Lisa ^a   Kuolee, Rhonda ^a   Harris, Greg ^a   Tram, Kha ^b   Yan, Hongbin ^b   Chen, Wangxue ^a,b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b BROCK UNIVERSITY   (Canada)

Author keywords

Acinetobacter baumannii; c di GMP; Mice; Neutrophils; Pneumonia

Indexed keywords

3',5' CYCLIC DIGUANYLIC ACID; CHEMOKINE; GUANOSINE PHOSPHATE; IMMUNOMODULATING AGENT; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HOST RESISTANCE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SECOND MESSENGER; TREATMENT OUTCOME;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADMINISTRATION, INTRANASAL; ANIMALS; CHEMOKINE CCL2; CHEMOKINE CCL3; CHEMOKINE CCL5; CHEMOKINE CXCL2; CHEMOKINES; CYCLIC GMP; FEMALE; LUNG; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; TIME FACTORS;

EID: 80051864478     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.03.024     Document Type: Article

References (29)

1. C.M. Luna, and P.K. Aruj Nosocomial Acinetobacter pneumonia Respirology 12 2007 787 791 (Pubitemid 350045715)
2. M.L. Joly-Guillou Clinical impact and pathogenicity of Acinetobacter Clin Microbiol Infect 11 2005 868 873
3. R. Gaynes, and J.R. Edwards Overview of nosocomial infections caused by Gram-negative bacilli Clin Infect Dis 41 2005 848 854 (Pubitemid 41266753)
4. L.C. Kuo, C.C. Lai, C.H. Liao, C.K. Hsu, Y.L. Chang, and C.Y. Chang Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome Clin Microbiol Infect 13 2007 196 198
5. P.E. Fournier, and H. Richet The epidemiology and control of Acinetobacter baumannii in health care facilities Clin Infect Dis 42 2006 692 699 (Pubitemid 43271386)
6. L. Dijkshoorn, A. Nemec, and H. Seifert An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii Nat Rev Microbiol 5 2007 939 951 (Pubitemid 350131182)
7. H. Yan, and W. Chen 3′,5′-Cyclic diguanylic acid: a small nucleotide that makes big impacts Chem Soc Rev 39 2010 2914 2924
8. A.D. Tischler, and A. Camilli Cyclic diguanylate (c-di-GMP) regulates Vibrio cholerae biofilm formation Mol Microbiol 53 2004 857 869 (Pubitemid 39036965)
9. U. Romling, M. Gomelsky, and M.Y. Galperin c-di-GMP: the dawning of a novel bacterial signalling system Mol Microbiol 57 2005 629 639 (Pubitemid 41025947)
10. H. Yan, X. Wang, R. KuoLee, and W. Chen Synthesis and immunostimulatory properties of the phosphorothioate analogues of cdiGMP Bioorg Med Chem Lett 18 2008 5631 5634
11. D.K.R. Karaolis, T.K. Means, D. Yang, M. Takahashi, T. Yoshimura, and E. Muraille Bacterial c-di-GMP is an immunostimulatory molecule J Immunol 178 2007 2171 2181 (Pubitemid 46233415)
12. D.K. Karaolis, M.W. Newstead, X. Zeng, M. Hyodo, Y. Hayakawa, and U. Bhan Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia Infect Immun 75 2007 4942 4950 (Pubitemid 47502166)
13. T. Ebensen, K. Schulze, P. Riese, M. Morr, and C.A. Guzman The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant Clin Vaccine Immunol 14 2007 952 958
14. T. Ebensen, K. Schulze, P. Riese, C. Link, M. Morr, and C.A. Guzman The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties Vaccine 25 2007 1464 1469 (Pubitemid 46074291)
15. A.D. Ogunniyi, J.C. Paton, A.C. Kirby, J.A. McCullers, J. Cook, and M. Hyodo c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection Vaccine 26 2008 4676 4685
16. D.K. Karaolis, M.H. Rashid, R. Chythanya, W. Luo, M. Hyodo, and Y. Hayakawa c-di-GMP (3′-5′-cyclic diguanylic acid) inhibits Staphylococcus aureus cell-cell interactions and biofilm formation Antimicrob Agents Chemother 49 2005 1029 1038 (Pubitemid 40327720)
17. D.L. Hu, K. Narita, M. Hyodo, Y. Hayakawa, A. Nakane, and D.K. Karaolis c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection Vaccine 27 2009 4867 4873
18. H. Yan, and A.L. Aguilar Synthesis of 3′,5′-cyclic diguanylic acid (cdiGMP) using 1-(4-chlorophenyl)-4-ethoxypiperidin-4-yl as a protecting group for 2′-hydroxy functions of ribonucleosides Nucleosides Nucleotides Nucleic Acids 26 2007 189 204
19. H. van Faassen, R. KuoLee, G. Harris, X. Zhao, J.W. Conlan, and W. Chen Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice Infect Immun 75 2007 5597 5608 (Pubitemid 350207796)
20. W. Chen, E.A. Havell, L.L. Moldawer, K.W. McIntyre, R.A. Chizzonite, and A.G. Harmsen Interleukin 1: an important mediator of host resistance against Pneumocystis carinii J Exp Med 176 1992 713 718
21. R. KuoLee, G. Harris, J.W. Conlan, and W. Chen Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis Vaccine 25 2007 3781 3791 (Pubitemid 46589759)
22. J.W. Conlan, and R.J. North Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody J Exp Med 179 1994 259 268
23. M. Marks, T. Burns, M. Abadi, B. Seyoum, J. Thornton, and E. Tuomanen Influence of neutropenia on the course of serotype 8 pneumococcal pneumonia in mice Infect Immun 75 2007 1586 1597 (Pubitemid 46559422)
24. S. Knapp, C.W. Wieland, S. Florquin, R. Pantophlet, L. Dijkshoorn, and N. Tshimbalanga Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia Am J Respir Crit Care Med 173 2006 122 129 (Pubitemid 43069797)
25. H. Yan, R. KuoLee, K. Tram, H. Qiu, J. Zhang, and G.B. Patel 3′,5′-Cyclic diguanylic acid elicits mucosal immunity against bacterial infection Biochem Biophys Res Commun 387 2009 581 584
26. U. Jenal Cyclic di-guanosine-monophosphate comes of age: a novel secondary messenger involved in modulating cell surface structures in bacteria? Curr Opin Microbiol 7 2004 185 191 (Pubitemid 38447053)
27. P. Ross, H. Weinhouse, Y. Aloni, D. Michaeli, P. Weinberger-Ohana, and R. Mayer Regulation of cellulose synthesis in Acetobacter xylinum by cyclic diguanylic acid Nature 325 1987 279 281 (Pubitemid 17049892)
28. S.L. Deshmane, S. Kremlev, S. Amini, and B.E. Sawaya Monocyte chemoattractant protein-1 (MCP-1): an overview J Interferon Cytokine Res 29 2009 313 326
29. S.M. McWhirter, R. Barbalat, K.M. Monroe, M.F. Fontana, M. Hyodo, and N.T. Joncker A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP J Exp Med 206 2009 1899 1911